PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2026Journal of Medicinal Chemistry0 citations

Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs

View Full Paper
SGShi-Xian GanRZRu-Lei ZhangCGCongying Guo

Key Points

  • The research aims to develop a fluorinated neuromuscular blocking agent with enhanced activity and biosafety.
  • Investigated the activity profile of fluorinated agents for neuromuscular blockade and reversal.
  • Conducted assessments on the safety and efficacy of these agents in a controlled environment.
  • Demonstrated significant improvements in blockade duration and safety compared to traditional agents.
  • Established a viable framework for on-demand reversal of neuromuscular blockade.

Abstract

. The two agents thus form a promising partnership featuring ultralong-acting blockade and on-demand reversal.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gan et al. (2026) studied this question.

synapsesocial.com/papers/6a1d216202fbce91306376a4https://doi.org/10.1021/acs.jmedchem.6c01353
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of Trifluoromethyl and Trifluoromethoxy Groups in Medicinal Chemistry: Implications for Drug Design2025 · 72 citations
  2. 2Prelude to pancuronium and vecuronium2000 · 18 citations
  3. 3The C–H···Cl hydrogen bond: does it exist?1999 · 340 citations
  4. 4PIPECURONIUM AND PANCURONIUM: COMPARISON OF PHARMACOKINETICS AND DURATION OF ACTION †1988 · 39 citations
  5. 5Advancements and strategic approaches in catenane synthesis2024 · 48 citations